Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision text updated from v3.3.3 to v3.3.4 in the page header.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Locations section now lists Beijing Municipality as a separate location, replacing the previous combined Beijing Municipality Locations. Page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page shows a minor revision update from v3.2.0 to v3.3.2 in the header/footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRemoved a general government funding status notice about potential updates and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedFormatting and layout updates were applied without changing core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check107 days agoChange DetectedCore content updated with a government-operational notice and a version bump from v3.1.0 to v3.2.0; no other significant content changes detected.SummaryDifference6%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.